Budesonide Inhalation Suspension
Product Images NDC 68788-8503

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Budesonide Inhalation (NDC 68788-8503). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Budesonide Inh Susp 0.5mg Per2ml (Dd74e446 7c1b 4f02 9c73 Ba716572ee77 00)

Label of budesonide inhalation suspension 0.5 mg/2 mL by Preferred Pharmaceuticals, Inc. The label specifies it is a single-dose 2 mL sterile suspension of micronized budesonide for respiratory inhalation. It includes storage and usage warnings, manufacturer Lupin Pharmaceuticals, Inc., and cautions against improper transfer or usage.*

FDA Label Image

Chemical Structure (E986c849 75fc 4c78 B593 1bd0c878adf8 01)

Chemical structure of budesonide inhalation, displaying the molecular arrangement of atoms and bonds characteristic of this corticosteroid used for respiratory inhalation suspension.*

FDA Label Image

Image (E986c849 75fc 4c78 B593 1bd0c878adf8 02)

A line graph showing mean change from baseline in nighttime asthma symptoms over 12 weeks. The graph compares four groups: placebo, 0.25 mg once daily, 0.5 mg once daily, and 1.0 mg once daily. The vertical axis measures mean change from baseline, and the horizontal axis represents time intervals from baseline to weeks 10-12. The treated groups show a decrease in symptoms compared to placebo, with p-values for significance noted for each dose.*

FDA Label Image

Image (E986c849 75fc 4c78 B593 1bd0c878adf8 03)

A line graph titled 'Nighttime Asthma Change from Baseline' showing mean change from baseline in nighttime asthma symptoms over 12 weeks. The x-axis represents time intervals from baseline through week 10-12; the y-axis shows mean change values ranging from -0.6 to 0.1. Three lines depict different groups: placebo, 0.25 mg twice daily, and 0.5 mg twice daily. The placebo group shows slight positive or no improvement, while both budesonide inhalation dosing groups show greater negative change (improvement) over time. P-values for 0.25 mg and 0.5 mg doses are 0.022 and 0.021, respectively.*

FDA Label Image

Image (E986c849 75fc 4c78 B593 1bd0c878adf8 04)

A line graph titled 'Nighttime Asthma Change from Baseline' showing mean change from baseline nighttime asthma symptoms over a 12-week period. The x-axis represents time in weeks from baseline to week 0-12, and the y-axis shows mean change values ranging from 0.0 to -0.6. The graph compares five treatment groups: placebo, 0.25 mg once daily, 0.25 mg twice daily, 0.5 mg twice daily, and 1.0 mg once daily, each represented by different symbols. P-values for comparisons are provided below the graph.*

FDA Label Image

Instructions (E986c849 75fc 4c78 B593 1bd0c878adf8 05)

An instructional line drawing showing hands holding a blister pack while peeling back the foil to remove a single dose. The illustration likely demonstrates how to open the medication blister for budesonide inhalation suspension doses.*

FDA Label Image

Instructions (E986c849 75fc 4c78 B593 1bd0c878adf8 06)

An instructional diagram showing a hand holding a small inhalation suspension vial, with a rotating arrow at the base indicating to twist or turn the vial before use. The illustration emphasizes proper vial handling for budesonide inhalation suspension.*

FDA Label Image

Instructions (E986c849 75fc 4c78 B593 1bd0c878adf8 07)

An instructional illustration showing a person holding a small ampule with both hands, one hand at the base and the other at the top. A curved arrow indicates a twisting motion to open the ampule, demonstrating how to prepare the medication for use.*

FDA Label Image

Instructions (E986c849 75fc 4c78 B593 1bd0c878adf8 08)

An instructional illustration showing a person holding a respiratory inhalation device with one hand and using the other hand to insert or prepare the inhalation suspension for use. This diagram is related to budesonide inhalation suspension administration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.